10% OFF DISCOUNT FOR VETERANS & FIRST RESPONDERS 
We are committed to making a positive impact on mental health awareness! Five percent [5%] of all profits will be directly donated to mental health related causes.
Anxiety is a normal response to stress, but persistent or excessive anxiety can interfere with work, relationships, sleep, and everyday routines. Anxiety disorders can include generalized anxiety disorder, social anxiety disorder, panic disorder, and other conditions involving ongoing fear, worry, or avoidance.
These conditions are extremely common. The National Institute of Mental Health estimates that 19.1% of U.S. adults experience an anxiety disorder in a given year, while approximately 31.1% experience one at some point during their lives. Among adults with an anxiety disorder, about 22.8% experience serious impairment.
Psychotherapy and conventional medications remain the first-line treatments for most anxiety disorders. However, some people continue to experience significant symptoms despite trying multiple medications, therapy, or a combination of both. This is sometimes described as treatment-resistant or refractory anxiety.
For these patients, medically supervised ketamine therapy is being studied as a possible alternative.
Treatment commonly includes cognitive behavioral therapy, exposure-based therapy, stress-management strategies, and medications such as selective serotonin reuptake inhibitors, or SSRIs.
These approaches can be highly effective, but they may require time. Antidepressant medications can take several weeks to produce noticeable benefits, and some patients experience only partial improvement or unwanted side effects.
Ketamine is different because it affects the brain through pathways involving glutamate, rather than working primarily through serotonin. Researchers believe this may help explain why ketamine can produce changes more quickly in some patients.
Ketamine is an NMDA receptor antagonist. NMDA receptors are part of the brain’s glutamate system, which plays an important role in learning, memory, emotional processing, and neuroplasticity.
Neuroplasticity refers to the brain’s ability to adapt and form new connections. Researchers are investigating whether ketamine can temporarily create conditions that make it easier for the brain to move away from deeply reinforced patterns of fear, avoidance, and negative thinking.
This does not mean ketamine erases anxiety or traumatic memories. Rather, it may reduce symptom intensity and provide a period during which patients are better able to participate in therapy, develop healthier coping skills, or make progress that previously felt out of reach.
Research into ketamine therapy for anxiety remains smaller and less established than research into ketamine for treatment-resistant depression. Nevertheless, early findings are encouraging.
A systematic review and meta-analysis of randomized trials concluded that acute ketamine treatment may be broadly effective across several treatment-resistant anxiety-spectrum disorders. The authors also found that benefits may be extended through maintenance treatment, while emphasizing that larger studies are still needed to clarify long-term effectiveness, dosing, side effects, and potential risks.
Another systematic review found evidence that ketamine can significantly reduce symptoms of refractory anxiety, although the researchers noted that the available studies were generally small and used varying treatment methods.
In one small study involving 12 patients with treatment-resistant generalized or social anxiety disorder, participants reported reduced anxiety within one hour of receiving ketamine. Improvements lasted for as long as seven days after some doses. Because the study was small and used subcutaneous ketamine rather than IV infusion, its findings should be viewed as preliminary rather than definitive.
A randomized, placebo-controlled trial involving adults with social anxiety disorder also found a significantly greater reduction on one established anxiety rating scale following ketamine compared with placebo, although not every outcome measure showed the same result.
A broader 2023 meta-analysis concluded that ketamine appeared to produce anxiety relief within the first 12 hours, with benefits sometimes lasting one to two weeks. The researchers called for additional studies on maintenance therapy and longer-term outcomes.
Ketamine is FDA-approved as an anesthetic, but it is not FDA-approved specifically for anxiety disorders. Its psychiatric use is considered off-label, meaning a licensed medical provider may prescribe it based on clinical judgment even though anxiety is not listed as an FDA-approved indication.
That distinction is important. Ketamine should not be portrayed as a guaranteed cure or a replacement for established anxiety treatments. It should be considered only after a thorough evaluation by a qualified medical professional.
At K Plus Clinics, treatment begins with a medical consultation to review your symptoms, health history, medications, previous treatments, and goals.
During an IV ketamine infusion, medication is administered gradually while medical professionals monitor your vital signs and comfort. Patients may experience temporary changes in perception, lightheadedness, nausea, increased blood pressure, or a sense of detachment.
Because judgment and coordination can remain impaired after treatment, patients need a responsible adult to drive them home and should avoid driving, working, drinking alcohol, or making important decisions for the remainder of the day.
Treatment schedules vary. Some patients begin with an initial series of infusions followed by occasional maintenance or booster sessions. The appropriate frequency depends on diagnosis, response, side effects, and the treating provider’s recommendations.
For people who have not found sufficient relief from conventional treatment, ketamine therapy may offer another option worth discussing with a medical provider.
Located in Winter Park, Florida, K Plus Clinics serves patients throughout Orlando and Central Florida. Every treatment plan is personalized, medically supervised, and based on an individual evaluation.
Ketamine therapy is not appropriate for everyone, and results vary. However, emerging research suggests it may provide rapid, short-term anxiety relief for some individuals with difficult-to-treat symptoms.
To learn whether ketamine therapy may be appropriate for you, contact K Plus Clinics in Winter Park to schedule a consultation.
